DePuy Synthes, Inc., a subsidiary of Johnson & Johnson, is a leading player in the global medical device industry, specialising in orthopaedic and neuro products. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, providing innovative solutions for joint reconstruction, trauma, and spinal surgery.
Founded in 1895, DePuy Synthes has achieved significant milestones, including the development of pioneering surgical techniques and advanced implant technologies. Their core offerings encompass a wide range of products, such as joint replacement systems and surgical instruments, distinguished by their commitment to quality and innovation.
With a strong market position, DePuy Synthes is recognised for its contributions to improving patient outcomes and enhancing surgical efficiency, making it a trusted name among healthcare professionals worldwide.
+39 vs industry average
DePuy Synthes, Inc.’s score of 62 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at DePuy Synthes, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has reduced its overall emissions by 23% since 2018
Reported emissions
No reported emissions data is available for DePuy Synthes, Inc. yet.
DePuy Synthes, Inc.'s reported carbon emissions
DePuy Synthes, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Johnson & Johnson, and as such, it inherits emissions data and climate commitments from its parent organisation.
While there are no documented reduction targets or specific emissions figures for DePuy Synthes, it aligns with the sustainability initiatives of Johnson & Johnson. This includes participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are aimed at reducing carbon footprints and promoting renewable energy usage.
As a subsidiary, DePuy Synthes is expected to contribute to the overarching climate goals set by Johnson & Johnson, which include significant commitments to reducing greenhouse gas emissions across all scopes. However, specific targets or achievements at the DePuy Synthes level have not been disclosed.
In summary, while DePuy Synthes does not provide its own emissions data or reduction targets, it is part of a larger corporate family that is actively engaged in climate commitments and sustainability efforts.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
DePuy Synthes, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for DePuy Synthes, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Johnson & Johnson
Carbon Disclosure Project
Inherited from Johnson & Johnson
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Johnson & Johnson
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for DePuy Synthes, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project